Akero Therapeutics, Inc. (AKRO)

Last Three Months

07-Feb-24 -- 06-May-24

Time Period:

Three Months
|
Year

($100.75K) Net Amount

Buy:	0	--
Sell:	($100.75K)	$20.15

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

15

0

1

+1

0

+2

0

+3

Two Year Chart

07-May-22 -- 06-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Mar-24 4:45 PM View:	13-Mar-24 Private Sale ($20.48K)	Yale Catriona Chief Development Officer		Akero Therapeutics, Inc. - AKRO	(1%) 78.42K to 77.69K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:42 PM View:	13-Mar-24 Private Sale ($17.54K)	Rolph Timothy Chief Scientific Officer		Akero Therapeutics, Inc. - AKRO	0% 183.18K to 182.56K	0	0	--	--	Show Txns Hide Txns

02-May-24 9:07 PM View:	01-May-24 Market Sale (Planned) ($100.75K)	Young Jonathan Chief Operating Officer		Akero Therapeutics, Inc. - AKRO	30% 245.64K to 318.31K	0	($100.75K) (2%)	--	$20.15	Show Txns Hide Txns

15-Mar-24 4:44 PM View:	13-Mar-24 Private Sale ($20.51K)	White William Richard Chief Financial Officer		Akero Therapeutics, Inc. - AKRO	(1%) 50.35K to 49.63K	0	0	--	--	Show Txns Hide Txns

15-Mar-24 4:43 PM View:	13-Mar-24 Private Sale ($55.78K)	Cheng Andrew President and CEO Director		Akero Therapeutics, Inc. - AKRO	0% 591.42K to 589.45K	0	0	--	--	Show Txns Hide Txns